Jennison Associates
OTIC

Jennison Associates’s Otonomy, Inc. OTIC Stock Holding History

Jennison Associates’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,599,706
Closed -$67.9M – 709
2017
Q2 		$67.9M Sell
3,599,706
-69,725
-2% -$972K 0.07% 227
2017
Q1 		$45M Sell
3,669,431
-139,620
-4% -$2.03M 0.05% 288
2016
Q4 		$60.6M Buy
3,809,051
+25,337
+0.7% +$424K 0.07% 236
2016
Q3 		$68.8M Sell
3,783,714
-92,754
-2% -$1.52M 0.07% 225
2016
Q2 		$61.6M Buy
3,876,468
+306,723
+9% +$4.57M 0.07% 248
2016
Q1 		$53.3M Buy
3,569,745
+888,654
+33% +$14M 0.06% 264
2015
Q4 		$74.4M Buy
2,681,091
+197,174
+8% +$4.91M 0.07% 223
2015
Q3 		$44.2M Buy
2,483,917
+141,056
+6% +$3.34M 0.05% 325
2015
Q2 		$53.9M Buy
2,342,861
+54,984
+2% +$1.54M 0.05% 322
2015
Q1 		$80.9M Buy
2,287,877
+1,044,595
+84% +$35.7M 0.07% 244
2014
Q4 		$41.4M Buy
1,243,282
+39,182
+3% +$1.05M 0.04% 357
2014
Q3 		$28.9M Buy
+1,204,100
New +$23.8M 0.03% 406

Other funds holding OTIC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates's OTIC Position: Q3 2017 in Review

Jennison Associates sold out of Otonomy, Inc. (OTIC) in Q3 2017, closing a stake of 3,599,706 shares — an estimated $67.9M sold.

Jennison Associates first reported a position in OTIC in Q3 2014 and held it in 12 quarters. The position peaked at $80.9M in Q1 2015. 84 funds tracked by Wall St. Rank hold OTIC as of Q3 2017.

  • Jennison Associates reported no remaining Otonomy, Inc. position as of Q3 2017 after selling out during the quarter.
  • Jennison Associates sold 3,599,706 Otonomy, Inc. shares in Q3 2017, an estimated $67.9M.
  • Jennison Associates first reported a position in Otonomy, Inc. in Q3 2014 and held it in 12 quarters.
  • Jennison Associates's Otonomy, Inc. position peaked at $80.9M in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2017.

Based on Jennison Associates's 13F filing for Q3 2017, filed 3 Nov 2017.